Global Reach BioDerm manufactures proprietary hydrocolloid products for urinary management with distribution in over 20 countries, presenting a solid opportunity to expand international sales, distributors, and hospital partnerships in new regions.

Hospital Adoption Men's Liberty Acute targets institutional and hospital use, offering a non-invasive alternative to Foley catheters that can help reduce CAUTI risk, suggesting upsell opportunities with care networks, purchasing groups, and infection prevention programs.

Securement Leadership CathGrip universal securement system with broad sizing and 11 SKUs positions BioDerm to cross-sell to hospitals, wound care, and enteral/urinary departments seeking streamlined, single-supplier solutions.

Direct-to-Consumer Growth Past D2C campaigns for UriCap Female and direct consumer initiatives indicate willingness to engage end users; explore physician office-to-patient channels, online marketing, and homecare program partnerships for wider distribution.

Operational Readiness Recent headcount reduction and a history of PE investment indicate potential strategic realignment; present optimized product bundles, channel partnerships, and cost-effective procurement options to align with current capacity and growth goals.